Why Immucell Corporation Is The Easiest Double In The Stockmarket
February 06, 2015 at 10:03 AM EST
Immucell Corporation is a completely unknown biotech stock; this research report is the first coverage ever, including an interview with the CEO. Shares are currently trading far below fair value, but that won't last long, as I expect the share price to double quickly.
